{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:45:31Z","timestamp":1784335531308,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.clbc.2017.09.010","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T23:30:28Z","timestamp":1506555028000},"page":"e205-e218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"John V.","family":"Hegde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1893-1183","authenticated-orcid":false,"given":"Deanna J.","family":"Attai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-292X","authenticated-orcid":false,"given":"Maggie L.","family":"DiNome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kusske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C.","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Hurvitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne B.","family":"Weidhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4292-5824","authenticated-orcid":false,"given":"Michael L.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2017.09.010_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.surge.2014.02.005","article-title":"Increasing trend of contralateral prophylactic mastectomy: what are the factors behind this phenomenon?","volume":"12","author":"Soran","year":"2014","journal-title":"Surgeon"},{"key":"10.1016\/j.clbc.2017.09.010_bib2","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1245\/s10434-011-1914-x","article-title":"Perceptions of contralateral breast cancer: an overestimation of risk","volume":"18","author":"Abbott","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib3","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1245\/s10434-015-4442-2","article-title":"Perceptions of contralateral breast cancer risk: a prospective, longitudinal study","volume":"22","author":"Portschy","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2010.32.7395","article-title":"Declining incidence of contralateral breast cancer in the United States from 1975 to 2006","volume":"29","author":"Nichols","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib5","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1245\/s10434-010-1091-3","article-title":"Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007","volume":"17","author":"Yao","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/SLA.0000000000001698","article-title":"Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer","volume":"265","author":"Wong","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2017.09.010_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/jamasurg.2017.0115","article-title":"State variation in the receipt of a contralateral prophylactic mastectomy among women who received a diagnosis of invasive unilateral early-stage breast cancer in the United States, 2004-2012","volume":"152","author":"Nash","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2017.09.010_bib8","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1245\/s10434-014-3930-0","article-title":"Survival analysis of contralateral prophylactic mastectomy: a question of selection bias","volume":"21","author":"Kruper","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/djq018","article-title":"Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients","volume":"102","author":"Bedrosian","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2017.09.010_bib10","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1245\/s10434-012-2299-1","article-title":"Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients","volume":"19","author":"Chung","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10549-013-2745-1","article-title":"Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002","volume":"142","author":"Yao","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.09.010_bib12","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1245\/s10434-014-3956-3","article-title":"Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor\u2013negative breast cancer","volume":"21","author":"Pesce","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-014-3160-y","article-title":"Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias","volume":"148","author":"Jatoi","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.09.010_bib14","first-page":"3748","article-title":"Predictors for contralateral prophylactic mastectomy in breast cancer patients","volume":"8","author":"Fu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.clbc.2017.09.010_bib15","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1245\/s10434-009-0641-z","article-title":"Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer","volume":"16","author":"Arrington","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib16","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1097\/SAP.0000000000000099","article-title":"Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction","volume":"72","author":"Pinell-White","year":"2014","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.clbc.2017.09.010_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jamcollsurg.2015.03.033","article-title":"Variation in contralateral prophylactic mastectomy rates according to racial groups in young women with breast cancer, 1998 to 2011: a report from the National Cancer Data Base","volume":"221","author":"Grimmer","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.clbc.2017.09.010_bib18","first-page":"1","article-title":"Factors associated with contralateral preventive mastectomy","volume":"7","author":"Yakoub","year":"2015","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.clbc.2017.09.010_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamasurg.2016.4749","article-title":"Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer","volume":"152","author":"Jagsi","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2017.09.010_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamasurg.2013.5689","article-title":"Social and clinical determinants of contralateral prophylactic mastectomy","volume":"149","author":"Hawley","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2017.09.010_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ejso.2015.02.017","article-title":"A\u00a0multidisciplinary team approach minimises prophylactic mastectomy rates","volume":"41","author":"Leff","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clbc.2017.09.010_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-147-7-200710020-00002","article-title":"Validity of models for predicting BRCA1 and BRCA2 mutations","volume":"147","author":"Parmigiani","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clbc.2017.09.010_bib24","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2017.09.010_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1996.14.1.103","article-title":"Graphs to estimate an individualized risk of breast cancer","volume":"14","author":"Benichou","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib26","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A\u00a0breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.clbc.2017.09.010_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/jmg.40.11.807","article-title":"Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme","volume":"40","author":"Amir","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.clbc.2017.09.010_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12957-015-0638-y","article-title":"The Manchester guidelines for contralateral risk-reducing mastectomy","volume":"13","author":"Basu","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10549-014-2890-1","article-title":"Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis","volume":"144","author":"Valachis","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.09.010_bib30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jama.283.5.617","article-title":"Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations","volume":"283","author":"Schrag","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2017.09.010_bib31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ijc.29032","article-title":"Improved overall survival after contralateral risk-reducing mastectomy in BRCA1\/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis","volume":"136","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2017.09.010_bib32","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1007\/s00330-015-4118-0","article-title":"The yield of pre-operative breast MRI in patients according to breast tissue density","volume":"26","author":"Seely","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2017.09.010_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.breast.2009.11.004","article-title":"Counterview: Pre-operative breast MRI (magnetic resonance imaging) is not recommended for all patients with newly diagnosed breast cancer","volume":"19","author":"Solin","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2017.09.010_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.breast.2009.11.003","article-title":"Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes","volume":"19","author":"Sardanelli","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2017.09.010_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1524-4741.2009.00833.x","volume":"15","author":"Moran","year":"2009","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2017.09.010_bib36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjsurg.2006.06.020","article-title":"Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma","volume":"192","author":"Vo","year":"2006","journal-title":"Am J Surg"},{"key":"10.1016\/j.clbc.2017.09.010_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/COC.0b013e318292f8a7","article-title":"Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer","volume":"38","author":"Soran","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10434-999-0542-1","article-title":"Issues of regret in women with contralateral prophylactic mastectomies","volume":"6","author":"Montgomery","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2017.09.010_bib39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/SLA.0000000000001216","article-title":"Prospective study of surgical decision-making processes for contralateral prophylactic mastectomy in women with breast cancer","volume":"263","author":"Parker","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2017.09.010_bib40","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","article-title":"Prospective validation of a 21-gene expression assay in breast cancer","volume":"373","author":"Sparano","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2017.09.010_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-016-4039-x","article-title":"A\u00a0model for individualized risk prediction of contralateral breast cancer","volume":"161","author":"Chowdhury","year":"2017","journal-title":"Breast Cancer Res Treat"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917305128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917305128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:17:04Z","timestamp":1761513424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820917305128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1526820917305128"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2017.09.010","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2017.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}